Product logins

Find logins to all Clarivate products below.


Diagnostic Imaging Systems | Market Insights | US | 2022

The COVID-19 pandemic has had a significant impact on the US diagnostic imaging market in the short term. Once the market stabilizes, however, the mature diagnostic imaging system market in the US will see slow growth through 2030. Although ongoing digitization efforts, declining ASPs, and rising demand for diagnostic imaging procedures, fueled by a growing aging population, will support increasing adoption of new technology among US healthcare providers, overall market expansion will be hindered by a saturated installed base of large imaging systems as well as consolidation of hospitals.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diagnostic imaging systems in the US across an 11-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Brazil
The Brazilian diagnostic imaging system market will expand moderately through 2034. The integration of AI capabilities and innovations is a key driver of this market expansion. However, the market…
Report
Surgical Navigation Systems – Market Insights – United States
Long-term growth will continue to be driven by demand for better patient outcomes and favorable results of clinical trials of navigation systems, which will drive the uptake of novel technologies…
Report
Diagnostic Imaging Systems – Market Insights – United States
The US diagnostic imaging system market will expand marginally through 2033. Changes in private insurer policies and the introduction of advanced products incorporating digital and AI technologies…
Report
Diagnostic Imaging Equipment Servicing – Market Insights – Europe
Following the recovery from the impact of the COVID-19 pandemic, Europe diagnostic imaging equipment servicing market will see modest growth throughout the forecast period. The market growth will…
Report
Biopsy Devices – Market Insights – Europe (Supplemental)
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…